Keimyumg University Dongsan Medical Center
Jung Gu, Daegu, Korea, Republic of
University in Daegu
1035 Dalgubeol-daero, Sindang-dong, Dalseo-gu, Daegu
About Keimyumg University Dongsan Medical Center
Keimyung University, abbreviated as KMU or Keimyung, is a private university located in Daegu, the fourth largest city in South Korea. The university takes roots from Jejungwon founded in 1899.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Bukwang Pharmaceutical
4
National Cancer Institute (NCI)
3
Pfizer
2
Pusan National University Hospital
1
Clinical Trials at Keimyumg University Dongsan Medical Center
During the past decade, Keimyumg University Dongsan Medical Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 5 clinical trials were completed, i.e. on
average, 500% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety and Antiviral Activity Study of Clevudine 30 mg QD in Patients With HBeAg(-) Chronic HBV
2003-07-01
2004-12-01
Terminated
80
Safety and Antiviral Activity Study of Clevudine 30 mg QD in Patient With Chronic HBV
2003-06-01
2004-11-01
Terminated
180
Safety and Antiviral Activity of Clevudine in Patients Who Have Completed the L-FMAU-301 or L-FMAU-302 Trials
2004-06-01
2006-03-01
Terminated
Durability of Antiviral Activity in Chronic HBV Patients Who Showed Complete Response in L-FMAU-301,302 or 303 Trial
2005-06-01
Completed
Fludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer
2007-09-01
2016-07-16
Completed
384
Post Marketing Surveillance Study To Observe Safety And Efficacy Of Sutene
2007-05-01
2015-03-01
Completed
520
Sunitinib Malate in Treating Patients With Persistent or Recurrent Clear Cell Ovarian Cancer
2010-04-19
2019-02-09
Completed
35
Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III-IV Clear Cell Ovarian Cancer
2010-08-01
2015-01-01
Completed
90
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Keimyumg University Dongsan Medical Center"
#1 collaborator was "NRG Oncology" with 3 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Keimyumg University Dongsan Medical Center
According to Clinical.Site data, the most researched conditions in "Keimyumg University Dongsan Medical Center" are
"Hepatitis B" (4 trials), "Cervical Adenocarcinoma" (1 trials), "Cervical Adenosquamous Cell Carcinoma" (1 trials), "Cervical Small Cell Carcinoma" (1 trials) and "Cervical Squamous Cell Carcinoma" (1 trials). Many other conditions were trialed in "Keimyumg University Dongsan Medical Center" in a lesser frequency.
Clinical Trials Intervention Types at Keimyumg University Dongsan Medical Center
Most popular intervention types in "Keimyumg University Dongsan Medical Center" are "Drug" (8 trials), "Other" (2 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Clevudine" (2 trials), "Laboratory Biomarker Analysis" (2 trials), "Carboplatin" (1 trials), "Docetaxel" (1 trials) and "Paclitaxel" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Keimyumg University Dongsan Medical Center
The vast majority of trials in "Keimyumg University Dongsan Medical Center" are
7 trials for "All" genders and 3 trials for "Female" genders.
Clinical Trials Status at Keimyumg University Dongsan Medical Center
Currently, there are NaN active trials in "Keimyumg University Dongsan Medical Center".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in Keimyumg University Dongsan Medical Center,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Keimyumg University Dongsan Medical Center, 1 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".